

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to cadmium ion (GO:0046686) | 5.30580842 |
| 2 | * response to zinc ion (GO:0010043) | 4.65513876 |
| 3 | regulation of mononuclear cell migration (GO:0071675) | 4.35428554 |
| 4 | regulation of macrophage chemotaxis (GO:0010758) | 4.31910575 |
| 5 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.27696218 |
| 6 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.15514276 |
| 7 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.15514276 |
| 8 | complement activation, alternative pathway (GO:0006957) | 3.97034546 |
| 9 | epoxygenase P450 pathway (GO:0019373) | 3.65636259 |
| 10 | barbed-end actin filament capping (GO:0051016) | 3.49553808 |
| 11 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.29511766 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.26693481 |
| 13 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.26331124 |
| 14 | apoptotic cell clearance (GO:0043277) | 3.25613203 |
| 15 | eosinophil chemotaxis (GO:0048245) | 3.25338107 |
| 16 | acute-phase response (GO:0006953) | 3.21495458 |
| 17 | omega-hydroxylase P450 pathway (GO:0097267) | 3.17235450 |
| 18 | virion attachment to host cell (GO:0019062) | 3.14057302 |
| 19 | adhesion of symbiont to host cell (GO:0044650) | 3.14057302 |
| 20 | regulation of triglyceride catabolic process (GO:0010896) | 3.11720973 |
| 21 | angiotensin maturation (GO:0002003) | 3.04659034 |
| 22 | regulation of vitamin metabolic process (GO:0030656) | 2.98068733 |
| 23 | low-density lipoprotein particle clearance (GO:0034383) | 2.97820669 |
| 24 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.96304961 |
| 25 | ethanol oxidation (GO:0006069) | 2.96005546 |
| 26 | adhesion of symbiont to host (GO:0044406) | 2.87657700 |
| 27 | eosinophil migration (GO:0072677) | 2.82600521 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82562155 |
| 29 | L-phenylalanine metabolic process (GO:0006558) | 2.82562155 |
| 30 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.78977857 |
| 31 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.73267430 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 2.68996995 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 2.68888115 |
| 34 | response to thyroid hormone (GO:0097066) | 2.63652183 |
| 35 | response to peptidoglycan (GO:0032494) | 2.63630474 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.61404775 |
| 37 | L-phenylalanine catabolic process (GO:0006559) | 2.61404775 |
| 38 | negative regulation of interleukin-12 production (GO:0032695) | 2.60338136 |
| 39 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.58867956 |
| 40 | vitamin A metabolic process (GO:0006776) | 2.57517182 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.54871225 |
| 42 | macromolecular complex remodeling (GO:0034367) | 2.54184673 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 2.54184673 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 2.54184673 |
| 45 | fibrinolysis (GO:0042730) | 2.54174708 |
| 46 | phospholipid efflux (GO:0033700) | 2.53888078 |
| 47 | glycosphingolipid catabolic process (GO:0046479) | 2.53847391 |
| 48 | fructose metabolic process (GO:0006000) | 2.52913639 |
| 49 | positive regulation of lipid catabolic process (GO:0050996) | 2.52271558 |
| 50 | response to copper ion (GO:0046688) | 2.51708419 |
| 51 | monocyte chemotaxis (GO:0002548) | 2.49457223 |
| 52 | positive regulation of cholesterol efflux (GO:0010875) | 2.49316344 |
| 53 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.47202645 |
| 54 | negative regulation of fibrinolysis (GO:0051918) | 2.46185088 |
| 55 | complement activation (GO:0006956) | 2.45695093 |
| 56 | * cellular response to metal ion (GO:0071248) | 2.41733259 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 2.39518899 |
| 58 | negative regulation of coagulation (GO:0050819) | 2.39064439 |
| 59 | negative regulation of hemostasis (GO:1900047) | 2.37561149 |
| 60 | negative regulation of blood coagulation (GO:0030195) | 2.37561149 |
| 61 | acylglycerol homeostasis (GO:0055090) | 2.36784174 |
| 62 | triglyceride homeostasis (GO:0070328) | 2.36784174 |
| 63 | monocyte differentiation (GO:0030224) | 2.36446792 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 2.36355623 |
| 65 | negative regulation of sterol transport (GO:0032372) | 2.36355623 |
| 66 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.36226993 |
| 67 | aromatic amino acid family catabolic process (GO:0009074) | 2.35694331 |
| 68 | lymphocyte chemotaxis (GO:0048247) | 2.35025973 |
| 69 | * response to transition metal nanoparticle (GO:1990267) | 2.34656794 |
| 70 | regulation of fibrinolysis (GO:0051917) | 2.34165392 |
| 71 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.33721776 |
| 72 | glycolipid catabolic process (GO:0019377) | 2.33057536 |
| 73 | regulation of protein activation cascade (GO:2000257) | 2.32378242 |
| 74 | lipid storage (GO:0019915) | 2.32342996 |
| 75 | regulation of complement activation (GO:0030449) | 2.29974289 |
| 76 | acute inflammatory response (GO:0002526) | 2.29613559 |
| 77 | NADH metabolic process (GO:0006734) | 2.28807087 |
| 78 | regulation of cholesterol storage (GO:0010885) | 2.28291473 |
| 79 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.28206908 |
| 80 | negative regulation of lipid storage (GO:0010888) | 2.27487518 |
| 81 | regulation of apoptotic cell clearance (GO:2000425) | 2.25934768 |
| 82 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.24780003 |
| 83 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24683532 |
| 84 | low-density lipoprotein particle remodeling (GO:0034374) | 2.24619551 |
| 85 | peptide catabolic process (GO:0043171) | 2.24027486 |
| 86 | glial cell migration (GO:0008347) | 2.23328811 |
| 87 | cholesterol efflux (GO:0033344) | 2.22334737 |
| 88 | cellular response to leptin stimulus (GO:0044320) | 2.20509755 |
| 89 | L-amino acid import (GO:0043092) | 2.20080648 |
| 90 | oxaloacetate metabolic process (GO:0006107) | 2.19165358 |
| 91 | complement activation, classical pathway (GO:0006958) | 2.19001604 |
| 92 | diacylglycerol metabolic process (GO:0046339) | 2.18948817 |
| 93 | response to magnesium ion (GO:0032026) | 2.18427261 |
| 94 | triglyceride catabolic process (GO:0019433) | 2.17508639 |
| 95 | exogenous drug catabolic process (GO:0042738) | 2.17426658 |
| 96 | protein activation cascade (GO:0072376) | 2.17307108 |
| 97 | response to leptin (GO:0044321) | 2.17183977 |
| 98 | positive regulation of cholesterol transport (GO:0032376) | 2.16879836 |
| 99 | * cellular response to zinc ion (GO:0071294) | 13.8779174 |
| 100 | cellular response to cadmium ion (GO:0071276) | 12.6657373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.20758699 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.13618995 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.06971703 |
| 4 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.31521385 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.72182356 |
| 6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64268036 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.61668521 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.53180788 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.49297949 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.29373456 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19997150 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.18857847 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.17386780 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.06432431 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.06015932 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96921383 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.89955690 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87943801 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83937646 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.81643775 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.73743476 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.72327741 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66863652 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63823390 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.63050823 |
| 26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.62907525 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.49728722 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.49405433 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48007602 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.45624811 |
| 31 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.42455988 |
| 32 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36213937 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34448145 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32677664 |
| 35 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29156742 |
| 36 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.26735907 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.25351016 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24485225 |
| 39 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24309250 |
| 40 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23701930 |
| 41 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22908009 |
| 42 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22325457 |
| 43 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20610948 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18688588 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17972763 |
| 46 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17867267 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.17576532 |
| 48 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16253832 |
| 49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16161593 |
| 50 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.14329135 |
| 51 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.14171931 |
| 52 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11316593 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10098929 |
| 54 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10040881 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09033624 |
| 56 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.08098283 |
| 57 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07848380 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07451436 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.05618626 |
| 60 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03923796 |
| 61 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03340597 |
| 62 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02489845 |
| 63 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02383583 |
| 64 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01990131 |
| 65 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01256226 |
| 66 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00252984 |
| 67 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00213339 |
| 68 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00168118 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 0.99842215 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97888020 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97888020 |
| 72 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97708664 |
| 73 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96606004 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96395406 |
| 75 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95977738 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95912262 |
| 77 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95654826 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.94285833 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94240149 |
| 80 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93036916 |
| 81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92126074 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91460128 |
| 83 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.89545850 |
| 84 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89131638 |
| 85 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88950430 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.88010715 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88003598 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87223841 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87072389 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.86999136 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.86468152 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84938984 |
| 93 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.83850535 |
| 94 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.83604820 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82607126 |
| 96 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82466821 |
| 97 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.81991670 |
| 98 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81717299 |
| 99 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.81709500 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81564240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 4.25781323 |
| 2 | MP0003011_delayed_dark_adaptation | 4.12527873 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.87522844 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 2.88553572 |
| 5 | MP0000343_altered_response_to | 2.79065627 |
| 6 | MP0005167_abnormal_blood-brain_barrier | 2.75289693 |
| 7 | MP0009785_altered_susceptibility_to | 2.69844401 |
| 8 | MP0003075_altered_response_to | 2.56694706 |
| 9 | MP0005365_abnormal_bile_salt | 2.39516057 |
| 10 | MP0003436_decreased_susceptibility_to | 2.38376863 |
| 11 | MP0005360_urolithiasis | 2.35291155 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.24929496 |
| 13 | MP0004510_myositis | 2.21574221 |
| 14 | MP0003195_calcinosis | 2.19723604 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.18810361 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.17589000 |
| 17 | MP0003303_peritoneal_inflammation | 2.14218125 |
| 18 | MP0009764_decreased_sensitivity_to | 2.07410325 |
| 19 | MP0000604_amyloidosis | 2.03718980 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 1.93470062 |
| 21 | MP0009278_abnormal_bone_marrow | 1.90466818 |
| 22 | MP0003690_abnormal_glial_cell | 1.85450892 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 1.83736108 |
| 24 | MP0006082_CNS_inflammation | 1.78828533 |
| 25 | MP0005166_decreased_susceptibility_to | 1.77853098 |
| 26 | MP0001853_heart_inflammation | 1.76441259 |
| 27 | MP0005670_abnormal_white_adipose | 1.74071906 |
| 28 | MP0002419_abnormal_innate_immunity | 1.70099207 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.67846812 |
| 30 | MP0003724_increased_susceptibility_to | 1.67058331 |
| 31 | MP0002998_abnormal_bone_remodeling | 1.66399967 |
| 32 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66335522 |
| 33 | MP0003329_amyloid_beta_deposits | 1.57677096 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.55376812 |
| 35 | MP0005595_abnormal_vascular_smooth | 1.53290461 |
| 36 | MP0005025_abnormal_response_to | 1.43345146 |
| 37 | MP0010368_abnormal_lymphatic_system | 1.41505608 |
| 38 | MP0003828_pulmonary_edema | 1.40877717 |
| 39 | MP0002971_abnormal_brown_adipose | 1.40614469 |
| 40 | MP0005023_abnormal_wound_healing | 1.36266367 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.36155074 |
| 42 | MP0000920_abnormal_myelination | 1.35351828 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.33252224 |
| 44 | MP0005451_abnormal_body_composition | 1.32576431 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.31184647 |
| 46 | MP0005387_immune_system_phenotype | 1.29592176 |
| 47 | MP0001790_abnormal_immune_system | 1.29592176 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.29294499 |
| 49 | MP0003279_aneurysm | 1.28463868 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.27001548 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.27001548 |
| 52 | MP0005164_abnormal_response_to | 1.26647475 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.23532547 |
| 54 | MP0008004_abnormal_stomach_pH | 1.20913950 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.20164761 |
| 56 | MP0003448_altered_tumor_morphology | 1.18349083 |
| 57 | MP0008469_abnormal_protein_level | 1.17567679 |
| 58 | MP0008874_decreased_physiological_sensi | 1.14978058 |
| 59 | MP0003186_abnormal_redox_activity | 1.12271417 |
| 60 | MP0003879_abnormal_hair_cell | 1.12063982 |
| 61 | MP0002138_abnormal_hepatobiliary_system | 1.11907463 |
| 62 | MP0008260_abnormal_autophagy | 1.11298765 |
| 63 | MP0005535_abnormal_body_temperature | 1.10882944 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.10077377 |
| 65 | MP0005332_abnormal_amino_acid | 1.04258051 |
| 66 | MP0002933_joint_inflammation | 1.03939125 |
| 67 | MP0000249_abnormal_blood_vessel | 1.03521053 |
| 68 | MP0001764_abnormal_homeostasis | 1.03272729 |
| 69 | MP0004883_abnormal_blood_vessel | 1.01607618 |
| 70 | MP0003172_abnormal_lysosome_physiology | 1.01568426 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.99638867 |
| 72 | MP0009763_increased_sensitivity_to | 0.99497874 |
| 73 | MP0005165_increased_susceptibility_to | 0.98370225 |
| 74 | MP0010155_abnormal_intestine_physiology | 0.96744385 |
| 75 | MP0003633_abnormal_nervous_system | 0.96494251 |
| 76 | MP0002295_abnormal_pulmonary_circulatio | 0.95164139 |
| 77 | MP0001501_abnormal_sleep_pattern | 0.94602309 |
| 78 | MP0005334_abnormal_fat_pad | 0.93007098 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.92546477 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91738681 |
| 81 | MP0009115_abnormal_fat_cell | 0.91676066 |
| 82 | MP0008438_abnormal_cutaneous_collagen | 0.90116838 |
| 83 | MP0001666_abnormal_nutrient_absorption | 0.88688607 |
| 84 | MP0000609_abnormal_liver_physiology | 0.88608208 |
| 85 | MP0004947_skin_inflammation | 0.86836393 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.86654953 |
| 87 | MP0000858_altered_metastatic_potential | 0.84765715 |
| 88 | MP0003868_abnormal_feces_composition | 0.84577015 |
| 89 | MP0002452_abnormal_antigen_presenting | 0.82625676 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.81087632 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.76087494 |
| 92 | MP0002723_abnormal_immune_serum | 0.74989211 |
| 93 | MP0000685_abnormal_immune_system | 0.74051623 |
| 94 | MP0001958_emphysema | 0.73402491 |
| 95 | MP0005448_abnormal_energy_balance | 0.73263001 |
| 96 | MP0001835_abnormal_antigen_presentation | 0.71195830 |
| 97 | MP0005390_skeleton_phenotype | 0.71079170 |
| 98 | MP0000750_abnormal_muscle_regeneration | 0.70713028 |
| 99 | MP0005423_abnormal_somatic_nervous | 0.69659542 |
| 100 | MP0003091_abnormal_cell_migration | 0.69560067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 6.48211940 |
| 2 | Complement deficiency (HP:0004431) | 6.20294190 |
| 3 | Abnormality of complement system (HP:0005339) | 5.21304994 |
| 4 | Glomerulonephritis (HP:0000099) | 4.27883238 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.23195354 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.23195354 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.23195354 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.19845203 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.10947196 |
| 10 | Xanthomatosis (HP:0000991) | 3.89183940 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.81126493 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.61718851 |
| 13 | Axonal loss (HP:0003447) | 3.47066591 |
| 14 | Amyloidosis (HP:0011034) | 3.38128931 |
| 15 | Malnutrition (HP:0004395) | 3.21677275 |
| 16 | Deep venous thrombosis (HP:0002625) | 3.19862792 |
| 17 | Mutism (HP:0002300) | 3.02787264 |
| 18 | Eczematoid dermatitis (HP:0000976) | 2.97680171 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.87959216 |
| 20 | Nephritis (HP:0000123) | 2.81469290 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.79281075 |
| 22 | Retinal atrophy (HP:0001105) | 2.76892623 |
| 23 | Hypertriglyceridemia (HP:0002155) | 2.67776663 |
| 24 | Myocardial infarction (HP:0001658) | 2.66160989 |
| 25 | Cerebral inclusion bodies (HP:0100314) | 2.64607958 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.62776844 |
| 27 | Dysostosis multiplex (HP:0000943) | 2.59861324 |
| 28 | Increased serum ferritin (HP:0003281) | 2.58117102 |
| 29 | Metaphyseal irregularity (HP:0003025) | 2.50410124 |
| 30 | Action tremor (HP:0002345) | 2.47000673 |
| 31 | Bone cyst (HP:0012062) | 2.44584795 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 2.41745152 |
| 33 | Joint hemorrhage (HP:0005261) | 2.39664659 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 2.34287535 |
| 35 | Loss of speech (HP:0002371) | 2.30558788 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 2.29834002 |
| 37 | Purpura (HP:0000979) | 2.29048609 |
| 38 | Abnormality of proline metabolism (HP:0010907) | 2.26096947 |
| 39 | Hydroxyprolinuria (HP:0003080) | 2.26096947 |
| 40 | Hematochezia (HP:0002573) | 2.25324712 |
| 41 | Prolonged partial thromboplastin time (HP:0003645) | 2.20086455 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19543566 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19543566 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19543566 |
| 45 | Thin bony cortex (HP:0002753) | 2.18920838 |
| 46 | Spontaneous hematomas (HP:0007420) | 2.18048364 |
| 47 | Hypophosphatemia (HP:0002148) | 2.15953504 |
| 48 | Muscle fiber splitting (HP:0003555) | 2.11790830 |
| 49 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.10917846 |
| 50 | Abnormality of the periventricular white matter (HP:0002518) | 2.10256281 |
| 51 | Bulbar palsy (HP:0001283) | 2.08592274 |
| 52 | Vacuolated lymphocytes (HP:0001922) | 2.08563933 |
| 53 | Myokymia (HP:0002411) | 2.06659946 |
| 54 | Nausea (HP:0002018) | 2.05753839 |
| 55 | Abnormality of iron homeostasis (HP:0011031) | 2.05504617 |
| 56 | Bone pain (HP:0002653) | 2.04571720 |
| 57 | Hemorrhage of the eye (HP:0011885) | 2.01780645 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.01220699 |
| 59 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.01220699 |
| 60 | Vertebral compression fractures (HP:0002953) | 2.00556614 |
| 61 | Supranuclear gaze palsy (HP:0000605) | 2.00409219 |
| 62 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.99246713 |
| 63 | Distal lower limb amyotrophy (HP:0008944) | 1.97668828 |
| 64 | Hypoalphalipoproteinemia (HP:0003233) | 1.97619766 |
| 65 | Distal lower limb muscle weakness (HP:0009053) | 1.96184742 |
| 66 | Symptomatic seizures (HP:0011145) | 1.95893095 |
| 67 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.95416162 |
| 68 | Dementia (HP:0000726) | 1.95198248 |
| 69 | Nuclear cataract (HP:0100018) | 1.93817200 |
| 70 | Generalized aminoaciduria (HP:0002909) | 1.93478882 |
| 71 | Hyperparathyroidism (HP:0000843) | 1.93275478 |
| 72 | Protuberant abdomen (HP:0001538) | 1.92849601 |
| 73 | Conjunctival telangiectasia (HP:0000524) | 1.91015481 |
| 74 | Pathologic fracture (HP:0002756) | 1.90583930 |
| 75 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90210743 |
| 76 | Widely patent fontanelles and sutures (HP:0004492) | 1.88935375 |
| 77 | Mediastinal lymphadenopathy (HP:0100721) | 1.88698231 |
| 78 | Skin nodule (HP:0200036) | 1.88535787 |
| 79 | Delayed epiphyseal ossification (HP:0002663) | 1.88483315 |
| 80 | Upper limb amyotrophy (HP:0009129) | 1.88172388 |
| 81 | Distal upper limb amyotrophy (HP:0007149) | 1.88172388 |
| 82 | Abnormality of the costochondral junction (HP:0000919) | 1.87989218 |
| 83 | Steatorrhea (HP:0002570) | 1.86858439 |
| 84 | Cerebral hemorrhage (HP:0001342) | 1.84023714 |
| 85 | Visceral angiomatosis (HP:0100761) | 1.80881022 |
| 86 | Hypobetalipoproteinemia (HP:0003563) | 1.80288474 |
| 87 | Neuronal loss in central nervous system (HP:0002529) | 1.79960333 |
| 88 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79448565 |
| 89 | Fat malabsorption (HP:0002630) | 1.78756322 |
| 90 | Orchitis (HP:0100796) | 1.77144506 |
| 91 | Intrahepatic cholestasis (HP:0001406) | 1.75577074 |
| 92 | Progressive visual loss (HP:0000529) | 1.73817576 |
| 93 | Abnormal eating behavior (HP:0100738) | 1.73567574 |
| 94 | Polycythemia (HP:0001901) | 1.73106413 |
| 95 | Acanthosis nigricans (HP:0000956) | 1.72126768 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 1.70716275 |
| 97 | Increased CSF protein (HP:0002922) | 1.69922510 |
| 98 | Gingivitis (HP:0000230) | 1.69821672 |
| 99 | Abnormality of the nasal mucosa (HP:0000433) | 1.68667395 |
| 100 | Congenital stationary night blindness (HP:0007642) | 1.67999426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.49590045 |
| 2 | NME2 | 3.23729534 |
| 3 | TGFBR2 | 3.09879949 |
| 4 | DDR2 | 3.08176798 |
| 5 | IRAK3 | 2.73340447 |
| 6 | TESK1 | 2.49297167 |
| 7 | RIPK1 | 2.43839465 |
| 8 | PRPF4B | 2.31616927 |
| 9 | RIPK4 | 2.06448267 |
| 10 | TAOK2 | 2.05260248 |
| 11 | ARAF | 2.04596550 |
| 12 | ABL2 | 1.97269191 |
| 13 | LATS2 | 1.87250514 |
| 14 | BLK | 1.79569283 |
| 15 | GRK7 | 1.75864074 |
| 16 | TYK2 | 1.71443964 |
| 17 | PDK2 | 1.66761353 |
| 18 | MAP3K13 | 1.64506867 |
| 19 | PINK1 | 1.62585663 |
| 20 | MAP3K11 | 1.60884200 |
| 21 | CSK | 1.57301307 |
| 22 | MAP3K3 | 1.56574692 |
| 23 | MOS | 1.56457442 |
| 24 | CAMKK2 | 1.55870365 |
| 25 | LIMK1 | 1.55280349 |
| 26 | GRK1 | 1.50508287 |
| 27 | PAK6 | 1.46657345 |
| 28 | DAPK2 | 1.45917230 |
| 29 | CDC42BPA | 1.41578411 |
| 30 | PRKG2 | 1.38822493 |
| 31 | MATK | 1.35322417 |
| 32 | ACVR1B | 1.35101280 |
| 33 | MAP3K1 | 1.29576992 |
| 34 | EPHB2 | 1.28704806 |
| 35 | TBK1 | 1.21733304 |
| 36 | MYLK | 1.18355029 |
| 37 | MAP3K12 | 1.10368755 |
| 38 | PDGFRA | 1.09081492 |
| 39 | FGR | 1.02943693 |
| 40 | JAK1 | 0.95764905 |
| 41 | MAPK12 | 0.93818997 |
| 42 | MAP3K14 | 0.93536361 |
| 43 | PDPK1 | 0.93154044 |
| 44 | CAMK2G | 0.88778912 |
| 45 | NTRK3 | 0.85591005 |
| 46 | EPHB1 | 0.85359709 |
| 47 | PIM2 | 0.83722230 |
| 48 | LMTK2 | 0.79473752 |
| 49 | PRKAA2 | 0.78906231 |
| 50 | KSR2 | 0.76648646 |
| 51 | CAMKK1 | 0.76100066 |
| 52 | ADRBK2 | 0.75766783 |
| 53 | MAPKAPK3 | 0.74810212 |
| 54 | TAOK1 | 0.73973761 |
| 55 | TYRO3 | 0.71814204 |
| 56 | ZAP70 | 0.70636178 |
| 57 | MAPK4 | 0.68621572 |
| 58 | EPHA4 | 0.67218298 |
| 59 | DMPK | 0.66608630 |
| 60 | JAK2 | 0.66382245 |
| 61 | EPHA3 | 0.65505123 |
| 62 | GRK5 | 0.65303143 |
| 63 | PAK4 | 0.65137366 |
| 64 | DAPK3 | 0.64089135 |
| 65 | CAMK2B | 0.63396030 |
| 66 | TTN | 0.63116563 |
| 67 | TESK2 | 0.62829004 |
| 68 | IKBKE | 0.60389674 |
| 69 | BMX | 0.58827382 |
| 70 | IKBKB | 0.58020027 |
| 71 | PDGFRB | 0.55693633 |
| 72 | CLK1 | 0.55491505 |
| 73 | PDK1 | 0.55461659 |
| 74 | CAMK2D | 0.55274657 |
| 75 | PRKACG | 0.54436369 |
| 76 | KDR | 0.52862959 |
| 77 | CSF1R | 0.52000348 |
| 78 | GSK3A | 0.50096324 |
| 79 | MAP2K3 | 0.47282215 |
| 80 | MAP3K9 | 0.46731180 |
| 81 | DAPK1 | 0.46255120 |
| 82 | JAK3 | 0.45955706 |
| 83 | PRKCG | 0.45742243 |
| 84 | SGK3 | 0.45436577 |
| 85 | MAP2K6 | 0.44724874 |
| 86 | TRIB3 | 0.43671202 |
| 87 | MAPK7 | 0.43443293 |
| 88 | SGK223 | 0.42932664 |
| 89 | SGK494 | 0.42932664 |
| 90 | CDK5 | 0.42857747 |
| 91 | ROCK1 | 0.42807052 |
| 92 | PRKCD | 0.42799094 |
| 93 | TGFBR1 | 0.42585838 |
| 94 | TIE1 | 0.42290104 |
| 95 | ILK | 0.41749015 |
| 96 | CAMK1 | 0.41113249 |
| 97 | MAP3K6 | 0.41049154 |
| 98 | CDK15 | 0.38236702 |
| 99 | PRKCA | 0.37895223 |
| 100 | CAMK1D | 0.37852996 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Mineral absorption_Homo sapiens_hsa04978 | 4.79122655 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81084779 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.26377422 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.19438041 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.16641914 |
| 6 | Prion diseases_Homo sapiens_hsa05020 | 2.11772754 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 1.97358506 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93194033 |
| 9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89141005 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.83440205 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.78438629 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.74038397 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.71769550 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.63597956 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.63457410 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62456236 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60559620 |
| 18 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.56158533 |
| 19 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54585184 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52872511 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.51695144 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51413217 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.47708694 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.45706206 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.43789853 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.34730263 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.34462279 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.33742278 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31750569 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30638834 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.29500148 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.28781907 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.20654160 |
| 34 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15953293 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.15354963 |
| 36 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13726609 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12780233 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09819117 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02589482 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.01382914 |
| 41 | Phagosome_Homo sapiens_hsa04145 | 1.01200555 |
| 42 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.98058748 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 0.97792599 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93218027 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92878058 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92428729 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91862937 |
| 48 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87587899 |
| 49 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86586469 |
| 50 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.85849639 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.85268233 |
| 52 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.84919978 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84807124 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.81937609 |
| 55 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81535389 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81103632 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.80334278 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74984939 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74476201 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74020820 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.73925736 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73072789 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71060976 |
| 64 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.70986616 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70560911 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68779032 |
| 67 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68509725 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68413684 |
| 69 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67979078 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67161716 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66943289 |
| 72 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.65136147 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64009503 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61192930 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.60423310 |
| 76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59528333 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58564097 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.56005396 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54635881 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.54340986 |
| 81 | Bladder cancer_Homo sapiens_hsa05219 | 0.46714661 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.45436810 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42544132 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42432447 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40830519 |
| 86 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40320722 |
| 87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.39772056 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.39462127 |
| 89 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36133733 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.33814128 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33029748 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30520745 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28937096 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.28576898 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.28107538 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.27581446 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25607619 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.25456817 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.24767859 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.24647483 |

